课题基金 / 基金详情

Application study of a novel apoptogenic protein for the pathogenesis of atherosclerotic diseases

Application study of a novel apoptogenic protein for the pathogenesis of atherosclerotic diseases
新型凋亡蛋白在动脉粥样硬化疾病发病机制中的应用研究
批准号:
18590810
负责人:
YASUDA Osamu
金额:
$2.49万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

YASUDA Osamu的其他基金

相似基金

相关文献

中文摘要
翻译
Apop是一种蛋白质,最初作为一种未知功能的因子从培养的动脉粥样硬化平滑肌细胞中分离出来。我们最近发现Apop的表达通过从线粒体释放细胞色素c诱导培养的血管平滑肌细胞(SMC)凋亡。细胞色素c从通透性转换孔(permeability transition pore,PTP)的释放被认为在缺血/再氧合诱导的心肌细胞凋亡中起重要作用,这有助于心肌梗死后球囊血管成形术后心力衰竭的发展。本研究旨在探讨Apop在缺氧/复氧诱导的心肌细胞死亡中的作用。从2至3日龄的Sprague-Dawley大鼠的心室制备新生心肌细胞,并维持在补充有10%胎牛血清的DMEM中。使用电穿孔器将阻止Apop表达的反义质粒或对照载体引入心肌细胞中。然后将细胞在缺氧条件(1%O2)下孵育 关于我们 )48小时,然后再充氧2小时。MTT法检测细胞活力。抗凋亡的bcl-2家族蛋白,如bcl-2和bcl-xL不能阻止Apop诱导的细胞凋亡,而PTP的重要成分亲环素D的抑制剂可以阻止凋亡。这些结果表明Apop诱导的细胞凋亡不是通过bcl-2家族相关通道介导的,而可能需要线粒体膜上的PIP。将靶向Apop转录本的siRNA导入培养细胞中几乎完全消除Apop-GFP融合蛋白的绿色荧光,表明siRNA阻止Apop的表达。Western blot分析也证实了siRNA的抑制活性。在缺氧/复氧诱导的细胞死亡实验中,siRNA的引入抑制了caspase级联的激活和培养心肌细胞的死亡,而对照siRNA的引入既不影响caspase的活性也不影响存活率;抑制Apop的表达阻止了缺氧/复氧诱导的心肌细胞死亡,提示Apop蛋白可能在缺血再灌注损伤后心脏疾病的发生中发挥作用。少
英文摘要
Apop is a protein originally isolated as a factor of unlkown function from cultured atherosclerotic smooth muscle cells. We found recently that expression of Apop induces apoptosis of vascular smooth muscle cells (SMC) in culture by releasing cytochrome c from mitochondria. Release of cytochrome c from the permeability transition pore (PTP) is believed to play an important role in ischemia/reeoxygenation-induced cardiomyocyte apoptosis, which contributes the development of heart failure following balloon angioplasty after myocardial infarction. This study was performed to investigate the role of Apop in hypoxia/reoxygenation-induced death of cardiomyocytes. Neonatal cardiomyccybas were prepared from ventricles of 2- to 3-day-old Sprague-Dawley rats and maintained in DMEM supplemented with 10% fetal bovine serum. Antisense plasmid to prevent Apop expression or control vector was introduced into cardiomyocybes using an electroporator. Cells were then incubated in hypoxic condition (1% O2 … More ) for 48 hours followed by 2 hours of reoxygenation. Cell viability was assessed by MTT assay. Anti-apoptotic bcl-2 family proteins, such as bcl-2 and bcl-xL were unable to prevent Apop-induced apoptosis, while it was prevented by inhibitors of cyclophilin D, an important component of PTP. These findings indicate that the apoptosis induced by Apop is not mediated by bcl-2 family-related channels, but may require PIP on mitochondrial membrane. Introduction of siRNA targeted toward Apop transcript into cultured cells almost completely abolished the green fluorescence of Apop-GFP fusion protein, indicating that siRNA prevents the expression of Apop. The inhibitory activity of siRNA was also confirmed by Western blot analysis. In the experiments of hypoxia/reoxygenation-induced cell death, introduction of siRNA inhibited the activation of caspase-cascade and the death of cultured cardiomyccytes, whereas introduction of control siRNA affected neither caspase activity nor viability; Inhibition of Apop expression prevented hypoxia/reoxygenation-induced death of cardiomyocytes, suggesting that Apop protein may play roles in the development of cardiac diseases following ischemia-reperfusion injury. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tissue inhibitor of metalloproteinase-3 deficiency inhibits blood pressure elevation and myocardial microvascular remodeling induced by chronic administration of Nomega-nitro-L-arginine methyl ester in mice.
金属蛋白酶-3 缺乏组织抑制剂可抑制小鼠长期服用 Nomega-硝基-L-精氨酸甲酯诱导的血压升高和心肌微血管重塑。
DOI: --
发表时间: 2007
期刊: Hypertension Research 30(6)
影响因子: --
作者: [Yatomi, M, Takiguchi, Y et. al., Higuchi M]
通讯作者: Higuchi M
DOI: 10.1074/jbc.m512610200
发表时间: 2006-08-18
期刊: JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子: 4.8
作者: [Yasuda, Osamu, Fukuo, Keisuke, Ogihara, Toshio]
通讯作者: Ogihara, Toshio
Apop蛋白質の機能解析
Apop蛋白的功能分析
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Yasuda, O, Rakugi, H, Ogihara, 安田 修]
通讯作者: 安田 修
Two cases of Werner's Syndrome diagnosed by DNA analysis
DNA分析诊断两例沃纳氏综合症
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Yasuda, O, Kawamoto, H, Shindo, N, Sugimoto, K, Fujisawa, T, Ohishi, M, Rakugi, H, Ogihara, T]
通讯作者: T
23
    Physics beyond the standard model probed by neutrinos
    • 批准号:
      24540281
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2012
    • 负责人:
      YASUDA Osamu
    • 依托单位:
    Creation of the anti-aging therapy that assumed Apop gene as a target
    • 批准号:
      23590886
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      YASUDA Osamu
    • 依托单位:
    Phenomenology of physics which can be probed by neutrino experiments
    • 批准号:
      21540274
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2009
    • 负责人:
      YASUDA Osamu
    • 依托单位:
    Applied Reserch of Apop protein for the treatment of Atherosclerosis
    • 批准号:
      20590882
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      YASUDA Osamu
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位:
    双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
    • 批准号:
      81670594
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2016
    • 负责人:
      陈昊
    • 依托单位:
    Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
    • 批准号:
      81470791
    • 项目类别:
      面上项目
    • 资助金额:
      73.0万元
    • 批准年份:
      2014
    • 负责人:
      董家鸿
    • 依托单位: